SCHEMBL8259484

SCHEMBL8259484

COC(=O)c1c(OC)ccc2nc(C/C=C/C(=O)c3cc4ccccc4cn3)[nH]c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 2/20 0.36
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYSLTR2 Q9NS75 1/20 0.34
CYSLTR1 Q9Y271 1/20 0.34
TSHR P16473 1/20 0.33
MAPK10 P53779 1/20 0.33
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
ABL1 P00519 1/20 0.33
SRC P12931 1/20 0.33
ABCB1 P08183 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1201772 0.78 RAB9A (0.45) MAPTLMNASMN1; SMN2TSHRABL1
SCHEMBL1202202 0.66 HPGDS (0.45) MAPTLMNASMN1; SMN2TSHRABCB1
SCHEMBL29840564 0.66 LCK (0.56) KDM4EMAPTMAPK1ALDH1A1LMNA
SCHEMBL214090 0.66 LCK (0.56) KDM4EMAPTMAPK1ALDH1A1LMNA
SCHEMBL1202608 0.65 HDAC3 (0.41) KDM4EMAPK1MAPK10ABCB1ABCG2
Hydrochloric Acid SCHEMBL27800514 0.65 LCK (0.55) KDM4EMAPTMAPK1ALDH1A1LMNA
SCHEMBL3517826 0.64 DHODH (0.45) KDM4EALDH1A1LMNASMN1; SMN2GABRA1
SCHEMBL1201846 0.62 MAOB (0.43) MAPTSMN1; SMN2TSHRABCB1ABCG2
SCHEMBL1203117 0.60 MAOB (0.51) MAPTLMNASMN1; SMN2TSHRDRD2
SCHEMBL3519633 0.60 MEN1 (0.47) KDM4EMAPTALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006099379-A2 BENZAZOLE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE AS B-SECRETASE INHIBITORS TRANSTECH PHARMA, INC. (US) 2006-09-21 WO disclosed